Created in 2012 (United States), ENPEGRY own
61 sister brands
and 17478 competing brands.
The ENPEGRY brand is owned by Biogen Idec, a company listed in New York.
ENPEGRY is part of the Drug Manufacturers activity sector.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.